NFKB1 and metabolic dysfunction-associated steatotic liver disease: Within this view, NAFLD is associated with the activation of the nuclear factor-kappa beta (NF-κB), a master inflammatory mediator [6], as well as the suppression of the nuclear factor erythroid factor-2 (Nrf2), a major antioxidant transcription factor [7].